Since joining Schlich in February 2015, Alex has become a key player in the firm, now leading our Chemical and Pharmaceutical patent team and responsible for major clients. In addition, Alex has a key role in the firm’s marketing strategy and day-to-day management as part of our Operations Committee (joining forces with George Schlich, Andrew Clements and Keira Denton).

Founder, George Schlich, commented: “This is well deserved, Alex, great to have your further dedication to the firm through your role as Director!”

This progression commemorates Alex’s hard work and dedication to the company and we congratulate him on his Directorship.


Our articles are for general information only. They should not be considered specific legal advice, which is available upon request. All information in our articles is considered to be accurate at the date of publishing.

Latest Firm News

Schlich Attorneys Recognised as Rising Stars

Schlich Attorneys Recognised as Rising Stars

Sean qualified as a European Patent Attorney in 2019 and continues to provide excellent IP assistance to a range of clients, particularly those in the immunotherapy space.  By working closely with...

read more